These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32816306)

  • 1. Alteration of gammaretroviral vector integration patterns by insertion of histone and leucine zipper into integrase.
    Yang Y; Lee JE; Jeong HY; Shim JY; Baek MJ; Son MJ; Kim YJ; Noh H; Lim KI
    Biotechnol Bioeng; 2020 Dec; 117(12):3924-3937. PubMed ID: 32816306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting Retroviral Vector Integrations Away from Transcriptional Start Sites via DNA-Binding Protein Domain Insertion into Integrase.
    Nam JS; Lee JE; Lee KH; Yang Y; Kim SH; Bae GU; Noh H; Lim KI
    Mol Ther Methods Clin Dev; 2019 Mar; 12():58-70. PubMed ID: 30534579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.
    Gupta SS; Maetzig T; Maertens GN; Sharif A; Rothe M; Weidner-Glunde M; Galla M; Schambach A; Cherepanov P; Schulz TF
    J Virol; 2013 Dec; 87(23):12721-36. PubMed ID: 24049186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-mitotic BET-induced reshaping of integrase quaternary structure supports wild-type MLV integration.
    Borrenberghs D; Zurnic I; De Wit F; Acke A; Dirix L; Cereseto A; Debyser Z; Hendrix J
    Nucleic Acids Res; 2019 Feb; 47(3):1195-1210. PubMed ID: 30445610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.
    Felice B; Cattoglio C; Cittaro D; Testa A; Miccio A; Ferrari G; Luzi L; Recchia A; Mavilio F
    PLoS One; 2009; 4(2):e4571. PubMed ID: 19238208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BET proteins promote efficient murine leukemia virus integration at transcription start sites.
    Sharma A; Larue RC; Plumb MR; Malani N; Male F; Slaughter A; Kessl JJ; Shkriabai N; Coward E; Aiyer SS; Green PL; Wu L; Roth MJ; Bushman FD; Kvaratskhelia M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12036-41. PubMed ID: 23818621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
    Loyola L; Achuthan V; Gilroy K; Borland G; Kilbey A; Mackay N; Bell M; Hay J; Aiyer S; Fingerman D; Villanueva RA; Cameron E; Kozak CA; Engelman AN; Neil J; Roth MJ
    PLoS Pathog; 2019 Dec; 15(12):e1008154. PubMed ID: 31815961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancers are major targets for murine leukemia virus vector integration.
    De Ravin SS; Su L; Theobald N; Choi U; Macpherson JL; Poidinger M; Symonds G; Pond SM; Ferris AL; Hughes SH; Malech HL; Wu X
    J Virol; 2014 Apr; 88(8):4504-13. PubMed ID: 24501411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.
    Métais JY; Topp S; Doty RT; Borate B; Nguyen AD; Wolfsberg TG; Abkowitz JL; Dunbar CE
    Gene Ther; 2010 Jun; 17(6):799-804. PubMed ID: 20237508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET-Independent Murine Leukemia Virus Integration Is Retargeted
    Nombela I; Michiels M; Van Looveren D; Marcelis L; El Ashkar S; Van Belle S; Bruggemans A; Tousseyn T; Schwaller J; Christ F; Gijsbers R; De Rijck J; Debyser Z
    Microbiol Spectr; 2022 Aug; 10(4):e0147822. PubMed ID: 35852337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.
    Lim KI; Klimczak R; Yu JH; Schaffer DV
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12475-80. PubMed ID: 20616052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
    Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
    PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of novel retroviral integrase proteins.
    Ballandras-Colas A; Naraharisetty H; Li X; Serrao E; Engelman A
    PLoS One; 2013; 8(10):e76638. PubMed ID: 24124581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
    Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
    Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.
    Larue RC; Plumb MR; Crowe BL; Shkriabai N; Sharma A; DiFiore J; Malani N; Aiyer SS; Roth MJ; Bushman FD; Foster MP; Kvaratskhelia M
    Nucleic Acids Res; 2014 Apr; 42(8):4868-81. PubMed ID: 24520112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors.
    Studamire B; Goff SP
    Retrovirology; 2008 Jun; 5():48. PubMed ID: 18554410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene integration using the combination of a sequence-specific DNA-binding protein and phiC31 integrase.
    Nakanishi H; Higuchi Y; Yamashita F; Hashida M
    J Biotechnol; 2014 Sep; 186():139-47. PubMed ID: 25038544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy.
    El Ashkar S; Van Looveren D; Schenk F; Vranckx LS; Demeulemeester J; De Rijck J; Debyser Z; Modlich U; Gijsbers R
    Mol Ther Nucleic Acids; 2017 Jun; 7():231-245. PubMed ID: 28624199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements.
    El Ashkar S; De Rijck J; Demeulemeester J; Vets S; Madlala P; Cermakova K; Debyser Z; Gijsbers R
    Mol Ther Nucleic Acids; 2014 Jul; 3(7):e179. PubMed ID: 25072693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction.
    Aiyer S; Swapna GV; Malani N; Aramini JM; Schneider WM; Plumb MR; Ghanem M; Larue RC; Sharma A; Studamire B; Kvaratskhelia M; Bushman FD; Montelione GT; Roth MJ
    Nucleic Acids Res; 2014 May; 42(9):5917-28. PubMed ID: 24623816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.